NeuroOne Medical Technologies Corporation
NMTC | NASDAQ
$1.39
+$0.09 (+6.92%)
Sep 22, 2026, 1:04 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | 12.1M | 3.45M | 1.95M | 171.17K | 178.15K | 1.93M |
Cost of Revenue | 3.96M | 2.37M | 1.5M | 241.96K | 275.9K | 70.55K |
Gross Profit | 8.14M | 1.08M | 456.52K | -70.79K | -97.75K | 1.86M |
Operating Income | -4.23M | -11.89M | -11.96M | -10.03M | -10.22M | -4.9M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.61M | -12.32M | -11.86M | -10M | -9.95M | -13.64M |
Net Income | -3.61M | -12.32M | -11.86M | -10M | -9.95M | -13.64M |
Selling & General & Admin | 7.38M | 7.9M | 6.93M | 6.98M | 6.26M | 4.75M |
Research & Development | 4.98M | 5.07M | 6.94M | 4.93M | 3.93M | 2.08M |
Other Expenses | n/a | n/a | -1.46M | -1.95M | -64.81K | -70.55K |
Operating Expenses | 12.37M | 12.97M | 12.41M | 9.96M | 10.12M | 6.76M |
Interest Expense | 334.06K | 228.99K | n/a | n/a | 3.05K | 7.52M |
Selling & Marketing Expenses | n/a | 108.99K | 173.43K | 270.61K | 338.84K | n/a |
Cost & Expenses | 16.32M | 15.34M | 13.91M | 10.2M | 10.4M | 6.83M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 6.69M | 4.46M | 3.02M | 2.67M | 1.78M | 902.56K |
Shares Outstanding (Diluted) | 6.69M | 4.46M | 3.02M | 2.67M | 1.78M | 902.56K |
EPS (Basic) | -0.54 | -2.76 | -3.90 | -3.78 | -5.58 | -15.12 |
EPS (Diluted) | -0.54 | -2.76 | -3.90 | -3.78 | -5.58 | -15.12 |
EBITDA | -3.01M | -11.84M | -11.66M | -9.88M | -9.8M | -4.85M |
EBIT | -3.27M | -12.09M | -11.86M | -10M | -9.95M | -4.9M |
Depreciation & Amortization | 261.68K | 246.79K | 199.27K | 118.62K | 147.13K | 70.55K |
Add to Watchlist
Select watchlists to add or remove NMTC